TIG Advisors LLC’s Trillium Therapeutics Inc. TRIL Stock Holding History

TIG Advisors LLC’s Portfolio TRIL Stock Details TRIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-323,658	Closed	-$5.68M	–	392
2021 Q3	$5.68M	Buy	+323,658	New	+$3.78M	0.26%	59

Other funds holding TRIL

Optiver Holding Amsterdam, Netherlands $289B AUM 33.63% 1-Year Est. Return

TIG Advisors LLC's TRIL Position: Q4 2021 in Review

TIG Advisors LLC sold out of Trillium Therapeutics Inc. (TRIL) in Q4 2021, closing a stake of 323,658 shares — an estimated $5.68M sold.

TIG Advisors LLC first reported a position in TRIL in Q3 2021 and held it in 1 quarter. The position peaked at $5.68M in Q3 2021. 2 funds tracked by Wall St. Rank hold TRIL as of Q4 2021.

TIG Advisors LLC reported no remaining Trillium Therapeutics Inc. position as of Q4 2021 after selling out during the quarter.
TIG Advisors LLC sold 323,658 Trillium Therapeutics Inc. shares in Q4 2021, an estimated $5.68M.
TIG Advisors LLC first reported a position in Trillium Therapeutics Inc. in Q3 2021 and held it in 1 quarter.
TIG Advisors LLC's Trillium Therapeutics Inc. position peaked at $5.68M in Q3 2021.
2 funds tracked by Wall St. Rank held Trillium Therapeutics Inc. as of Q4 2021.

Based on TIG Advisors LLC's 13F filing for Q4 2021, filed 14 Feb 2022.